Lipids | BJC TV

Masterclass: Lipoprotein(a) – a suitable case for treatment?

10 December 2024

In this masterclass, Dr Dermot Neely and Dr Jai Cegla discuss the why, when and how of measuring lipoprotein(a) [Lp(a)], the current management of people with elevated Lp(a) and the future prospects for treatment.

Masterclass: Treating dyslipidaemia – special populations

8 August 2024

In this masterclass, Alison Pottle and Jai Cegla provide discuss screening for familial hypercholesterolaemia (FH), treatment advances in dyslipidaemia, the role of lipid apheresis in specific populations and the importance of patient education.

Masterclass: The cardio-pulmonary patient – diagnostic, treatment and prevention challenges

3 July 2024

Join us for this masterclass with Jennifer Quint and Paul Kalra as they discuss the diagnostic and treatment challenges that might be encountered when dealing with patients with cardio-pulmonary disease.

Masterclass: Hypertriglyceridaemia: from fish oils to fibrates

24 May 2024

Join us for this masterclass with Dermot Neely and Derek Connolly as they explore hypertriglyceridaemia, what this means for your health and ways in which it can be tackled and improved.

Masterclass: Looking at lipids – dyslipidemia in CVD prevention

30 April 2024

Watch Terry McCormack and Peter Green discuss the national guidelines for primary and secondary prevention of cardiovascular disease (CVD), risk assessment and recommended lipid targets for CVD, and the availability of smart open-access data tools that can reduce health inequalities and improve treatment outcomes for your patients.

Masterclass: Lipids – Non-statin approaches to treatment

5 March 2024

Watch Dr Rani Khatib and Dr Dermot Neely delve into non-statin lipid-lowering therapies in cardiovascular disease, including when they should be used and in which groups of patients.

QOF indicators for CVD prevention

8 August 2023

Join Dr Martin Godfrey and Dr Jim Moore as they discuss the topic of cardiovascular management in primary care, highlighting the review of the 2023 Quality and Outcomes Framework (QOF) indicators published by the NHS, cardiovascular disease (CVD) prevention and less-explored areas of therapy.